Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

NCT05918263 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT05918263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05918263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2024
Completion date
March 31, 2027
Enrollment
68 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer, prostatic neoplasms